ATP8B1 Gene Sequencing
Disease
Progressive familial intrahepatic cholestasis 1, benign recurrent intrahepatic cholestasis 1
Description
Mutations in ATP8B1 are associated with progressive familial intrahepatic cholestasis (PFIC1), which is inherited as an autosomal recessive condition. The main clinical features of PFIC1 are hepatomegaly, cholestasis, pruritus and low-normal GTP. Mutations in ATP8B1 can also result in another condition known as benign recurrent intrahepatic cholestasis (BRIC1).
Indications
- Progressive familial intrahepatic cholestasis 1
- benign recurrent intrahepatic cholestasis 1
Testing Methodology
Testing may be performed by Sanger sequencing of the entire coding regions and intron/exon boundaries of the ATP8B1 gene or by enrichment of the exons, flanking intronic and un-translated regions (5’ and 3’) of the ATP8B1 gene using TruSeq Custom Amplicon enrichment technology followed by next-generation sequencing Generation Sequencing (NGS)
Test Sensitivity
The sensitivity of Sanger sequencing is over 99% for the detection of nucleotide base changes, small deletions and insertions in the regions analyzed. Mutations in regulatory regions or other untranslated regions are not detected by this test. Large deletions involving entire single exons or multiple exons, large insertions and other complex genetic events have been reported in many of these genes and will not be identified using this test methodology. Rare primer site variants may lead to erroneous results.
The predicted sensitivity of Next-Generation Sequencing is approximately 98% for the detection of nucleotide base changes or homozygous deletions in the coding exons and exon/intron boundaries of the five genes analyzed. Mutations are confirmed by targeted sequencing of the fragment(s) containing the mutation(s). Heterozygous deletions, insertions, genetic recombination events, as well as mutations in regulatory regions or other untranslated regions are not detected by this test.
If the patient has received a liver transplant or recent blood transfusion, donor DNA may be present in the blood along with patient DNA (chimerism). In this case, additional testing may be required to rule out chimerism.
Turnaround Time
28 days
How to Order
Testing for this gene is available as part of the Cholestasis and Jaundice panels by next-generation sequencing. Single gene sequencing, deletion/duplication analysis and familial mutation analysis are also available for this gene. Download Heritable Liver Disease requisition.
References
Van der Woerd, W.L., S.W.C. van Mil, et al. (2010) "Familial Cholestasis: Progressive Familial Intrahepatic Cholestasis, Benign Recurrent Intrahepatic Cholestasis and Intrahepatic Cholestasis of Pregnancy." Best Practice & Research. Clinical Gastroenterology 24(5): 541-53.
